Unitedhealth Group Incorporated (UNH)

$439.2

-2.52

(-0.57%)

Market is closed - opens 7 PM, 15 Apr 2024
star icon

UnitedHealth Group Inc is a healthcare company that provides various health-related products and services, including insurance, pharmacy benefit management, and health information technology.

Insights on Unitedhealth Group Incorporated

  • Increasing Revenue

    Revenue is up for the last 7 quarters, 80.03B → 94.42B (in $), with an average increase of 2.7% per quarter

  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, 5.84B → 5.45B (in $), with an average decrease of 6.6% per quarter

Performance

  • $436.53
    $442.24
    $439.20
    downward going graph

    0.61%

    Downside

    Day's Volatility :1.29%

    Upside

    0.69%

    downward going graph
  • $438.90
    $552.52
    $439.20
    downward going graph

    0.07%

    Downside

    52 Weeks Volatility :20.56%

    Upside

    20.51%

    downward going graph

Returns

PeriodUnitedhealth Group IncorporatedSector (Health Care)Index (NASDAQ Composite)
3 Months
-15.4%
-1.1%
1.0%
6 Months
-18.37%
6.7%
12.8%
1 Year
-14.18%
3.2%
12.1%
3 Years
16.92%
17.2%
12.6%

Highlights

Market Capitalization
414.9B
Book Value
$96.06
Dividend Share
7.29
Dividend Yield
1.53%
Earnings Per Share (EPS)
23.87
PE Ratio
18.85
PEG Ratio
1.27
Wall Street Target Price
580.19
Profit Margin
6.02%
Operating Margin TTM
8.14%
Return On Assets TTM
7.79%
Return On Equity TTM
24.99%
Revenue TTM
371.6B
Revenue Per Share TTM
400.46
Quarterly Revenue Growth YOY
14.099999999999998%
Gross Profit TTM
79.6B
EBITDA
35.1B
Diluted Eps TTM
23.87
Quarterly Earnings Growth YOY
0.16
EPS Estimate Current Year
27.58
EPS Estimate Next Year
31.18
EPS Estimate Current Quarter
5.98
EPS Estimate Next Quarter
6.87

Analyst Recommendation

Buy
    86%Buy
    13%Hold
    0
    0%Sell
Based on 30 Wall street analysts offering stock ratings for Unitedhealth Group Incorporated(by analysts ranked 0 to 5 stars)
Based on 30 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
26
26
27
Hold
4
5
4
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 32.1%

Current $439.20
Target $580.19

Company Financials

FY18Y/Y Change
Revenue
224.9B
↑ 12.36%
Net Income
12.0B
↑ 13.53%
Net Profit Margin
5.33%
↑ 0.05%
FY19Y/Y Change
Revenue
240.3B
↑ 6.85%
Net Income
13.8B
↑ 15.46%
Net Profit Margin
5.76%
↑ 0.43%
FY20Y/Y Change
Revenue
255.6B
↑ 6.4%
Net Income
15.4B
↑ 11.3%
Net Profit Margin
6.03%
↑ 0.27%
FY21Y/Y Change
Revenue
285.3B
↑ 11.59%
Net Income
17.3B
↑ 12.22%
Net Profit Margin
6.06%
↑ 0.03%
FY22Y/Y Change
Revenue
322.1B
↑ 12.92%
Net Income
20.1B
↑ 16.4%
Net Profit Margin
6.25%
↑ 0.19%
FY23Y/Y Change
Revenue
371.6B
↑ 15.36%
Net Income
22.4B
↑ 11.24%
Net Profit Margin
6.02%
↓ 0.23%
Q3 FY22Q/Q Change
Revenue
80.4B
↑ 0.43%
Net Income
5.3B
↑ 3.79%
Net Profit Margin
6.55%
↑ 0.22%
Q4 FY22Q/Q Change
Revenue
81.9B
↑ 1.93%
Net Income
4.8B
↓ 9.52%
Net Profit Margin
5.81%
↓ 0.74%
Q1 FY23Q/Q Change
Revenue
91.1B
↑ 11.23%
Net Income
5.6B
↑ 17.85%
Net Profit Margin
6.16%
↑ 0.35%
Q2 FY23Q/Q Change
Revenue
91.8B
↑ 0.72%
Net Income
5.5B
↓ 2.44%
Net Profit Margin
5.96%
↓ 0.2%
Q3 FY23Q/Q Change
Revenue
92.4B
↑ 0.62%
Net Income
5.8B
↑ 6.7%
Net Profit Margin
6.32%
↑ 0.36%
Q4 FY23Q/Q Change
Revenue
94.4B
↑ 2.24%
Net Income
5.5B
↓ 6.61%
Net Profit Margin
5.78%
↓ 0.54%
FY18Y/Y Change
Total Assets
152.2B
↑ 9.47%
Total Liabilities
96.0B
↑ 10.29%
FY19Y/Y Change
Total Assets
173.9B
↑ 14.23%
Total Liabilities
111.7B
↑ 16.39%
FY20Y/Y Change
Total Assets
197.3B
↑ 13.46%
Total Liabilities
126.8B
↑ 13.45%
FY21Y/Y Change
Total Assets
212.2B
↑ 7.56%
Total Liabilities
135.7B
↑ 7.08%
FY22Y/Y Change
Total Assets
245.7B
↑ 15.79%
Total Liabilities
159.4B
↑ 17.41%
FY23Y/Y Change
Total Assets
278.4B
↑ 13.31%
Total Liabilities
179.5B
↑ 12.64%
Q3 FY22Q/Q Change
Total Assets
243.1B
↑ 5.6%
Total Liabilities
160.1B
↑ 7.45%
Q4 FY22Q/Q Change
Total Assets
245.7B
↑ 1.09%
Total Liabilities
159.4B
↓ 0.49%
Q1 FY23Q/Q Change
Total Assets
283.7B
↑ 15.46%
Total Liabilities
193.1B
↑ 21.15%
Q2 FY23Q/Q Change
Total Assets
280.2B
↓ 1.24%
Total Liabilities
188.0B
↓ 2.62%
Q3 FY23Q/Q Change
Total Assets
282.1B
↑ 0.68%
Total Liabilities
188.1B
↑ 0.04%
Q4 FY23Q/Q Change
Total Assets
278.4B
↓ 1.29%
Total Liabilities
179.5B
↓ 4.57%
FY18Y/Y Change
Operating Cash Flow
15.7B
↑ 15.57%
Investing Cash Flow
-12.4B
↑ 44.03%
Financing Cash Flow
-4.4B
↑ 26.85%
FY19Y/Y Change
Operating Cash Flow
18.5B
↑ 17.5%
Investing Cash Flow
-12.7B
↑ 2.54%
Financing Cash Flow
-5.6B
↑ 28.87%
FY20Y/Y Change
Operating Cash Flow
22.2B
↑ 20.1%
Investing Cash Flow
-12.5B
↓ 1.32%
Financing Cash Flow
-3.6B
↓ 36.18%
FY21Y/Y Change
Operating Cash Flow
22.3B
↑ 0.76%
Investing Cash Flow
-10.4B
↓ 17.24%
Financing Cash Flow
-7.5B
↑ 107.66%
FY22Y/Y Change
Operating Cash Flow
26.2B
↑ 17.29%
Investing Cash Flow
-28.5B
↑ 174.55%
Financing Cash Flow
4.2B
↓ 156.69%
Q3 FY22Q/Q Change
Operating Cash Flow
18.5B
↑ 169.96%
Investing Cash Flow
-13.1B
↑ 6.91%
Financing Cash Flow
-3.4B
↓ 461.1%
Q4 FY22Q/Q Change
Operating Cash Flow
-4.5B
↓ 124.44%
Investing Cash Flow
-28.5B
↑ 117.26%
Financing Cash Flow
4.4B
↓ 228.57%
Q1 FY23Q/Q Change
Operating Cash Flow
16.3B
↓ 460.18%
Investing Cash Flow
-11.0B
↓ 61.3%
Financing Cash Flow
13.2B
↑ 200.32%
Q2 FY23Q/Q Change
Operating Cash Flow
11.0B
↓ 32.43%
Investing Cash Flow
-11.7B
↑ 6.61%
Financing Cash Flow
-10.5B
↓ 179.29%
Q3 FY23Q/Q Change
Operating Cash Flow
6.9B
↓ 37.44%
Investing Cash Flow
-14.4B
↑ 22.46%
Financing Cash Flow
-7.1B
↓ 32.08%

Technicals Summary

Sell

Neutral

Buy

Unitedhealth Group Incorporated is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Unitedhealth Group Incorporated
Unitedhealth Group Incorporated
-10.18%
-18.37%
-14.18%
16.92%
90.79%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Unitedhealth Group Incorporated
Unitedhealth Group Incorporated
18.85
18.85
1.27
27.58
0.25
0.08
0.02
96.06
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Unitedhealth Group Incorporated
Unitedhealth Group Incorporated
Buy
$414.9B
90.79%
18.85
6.02%

Institutional Holdings

  • Vanguard Group Inc

    9.10%
  • BlackRock Inc

    7.85%
  • State Street Corporation

    4.94%
  • FMR Inc

    4.53%
  • Capital World Investors

    3.13%
  • T. Rowe Price Associates, Inc.

    2.82%

Corporate Announcements

  • Unitedhealth Group Incorporated Dividends March,2024

    In the quarter ending March,2024. Unitedhealth Group Incorporated has declared dividend of $1.88

    Read More

Company Information

UnitedHealth Group Inc. is a rapidly expanding health care and well-being company with customers in different parts of the world. These institutions affiliated with the UnitedHealth Group Inc. may provide better health facilities and exceptional medical benefits to their customers. Customers want safe, secure, and hygienic medical facilities and dispensaries for surgeries, heart transplants, cancer operations, chemotherapy, and other procedures. UnitedHealth Group Inc. has adopted a loan and financial savings model to cater to the demands of their customers who are facing shortage of essential medical funds, operation/surgery costs, transportation costs for cure, and many other issues. Since its inception in the year 1977, UnitedHealth Group Inc. has established itself as a reputable and well-known organisation in the eyes of international communities from across the globe. UnitedHealth Group Inc. was one of the first companies to use technological advancements in the healthcare industry to attract rich and powerful customers from different parts of the world in the multibillion-dollar well-being industry market. UnitedHealth Inc. is dedicated to increasing the reach and accessibility of its market services to underdeveloped and developing nations. Over the next decade, Healthcare and personal well-being sectors of the global economy have the potential to outpace current levels of consumption and customer demands for better well-being alternatives. Currently Unitedhealth Group Incorporated has a market cap of $414.92 Billion. It has a P.E ratio of 18.54. The shares of Unitedhealth Group Incorporated are trading at $441.72. .

Organization
Unitedhealth Group Incorporated
Employees
440000
CEO
Sir Andrew Philip Witty
Industry
Health Services

FAQs